SCHEMBL787773

SCHEMBL787773

CC#CC[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15091634 0.73
SCHEMBL20176029 0.73
SCHEMBL20522791 0.69
SCHEMBL4173037 0.69
SCHEMBL29126269 0.69
SCHEMBL11596205 0.69
SCHEMBL1679524 0.69
SCHEMBL9161862 0.68
SCHEMBL8665073 0.67
SCHEMBL4576665 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025067290-A1 PYRIMIDOPYRAZOLE COMPOUND, AND PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 广东东阳光药业股份有限公司 2025-04-03 WO disclosed
EP-3434668-B1 INDOLO-SUBSTITUTED-PIPERIDINE COMPOUNDS AS ESTROGEN RECEPTOR DEGRADING AGENT LUOXIN PHARMACEUTICAL SHANGHAI CO LTD (CN) 2020-08-26 EP disclosed
CN-108884035-B Substituted indoles as estrogen receptor down-modulators 罗欣药业(上海)有限公司 2020-03-13 CN disclosed
EP-3544974-A1 TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF BREAST CANCER Eisai R&D Management Co., Ltd. (JP) 2019-10-02 EP disclosed
EP-3544956-A1 TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE Eisai R&D Management Co., Ltd. (JP) 2019-10-02 EP disclosed
US-20190106414-A1 SUBSTITUTED-INDOLE-COMPOUNDS AS ESTROGEN RECEPTOR DOWN-REGULATORS Luoxin Healthcare Science and Technology Development (Beijing) Ltd. (CN) 2019-04-11 US disclosed
EP-3434668-A1 INDOLO-SUBSTITUTED-PIPERIDINE COMPOUNDS AS ESTROGEN RECEPTOR DEGRADING AGENT Luoxin Biotechnology (Shanghai) Co., Ltd. (CN) 2019-01-30 EP disclosed
WO-2018098251-A1 TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE EISAI R&D MANAGEMENT CO., LTD. (JP) 2018-05-31 WO disclosed
WO-2018098305-A1 TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF BREAST CANCER EISAI R&D MANAGEMENT CO., LTD. (JP) 2018-05-31 WO disclosed
EP-3302471-A1 TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE Eisai R&D Management Co., Ltd. (JP) 2018-04-11 EP disclosed
US-6673930-B2 PREPARING A SELECTIVE GLUCOCORTICOID RECEPTOR AGENTS BY CYCLIZATION, DEHALOGENATION, AMINATION, ETHERIFICATION, HYDROXYLATION ABBVIE INC. 2004-01-06 US disclosed
US-20030069427-A1 Process for the preparation of 5-(substituted)-10 methoxy-2,2,4-trimethyl-2,5-dihydro- 1H-chromeno [3,4-f] quinolines and derivatives thereof ABBVIE INC. 2003-04-10 US disclosed
WO-2003027117-A1 A PROCESS FOR THE PREPARATION OF 5-(SUBSTITUTED)-10-METHOXY-2,2,4-TRIMETHYL-2,5-DIHYDRO-1H-CHROMENO[3,4-F]QUINOLINES AND DERIVATIVES THEREOF ABBOTT LABORATORIES (US) 2003-04-03 WO disclosed
US-6518430-B1 The present invention relates to an efficient process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5- dihydro-1H-chromeno(3,4-f)quinolines. ABBOTT LABORATORIES 2003-02-11 US disclosed
US-5494989-A GAS AND VAPOR SEPARATION BEND RESEARCH, INC. (US) 1996-02-27 US disclosed
EP-0339516-B1 CATALYST AND PROCESS FOR THE PREPARATION OF POLYMERS OF TRI-SUBSTITUTED SILYLALKYNES AIR PRODUCTS AND CHEMICALS, INC. (US) 1993-06-09 EP disclosed
US-4902763-A USING GROUP V OR VI METAL HALIDE CATALYST AND TRIALKYLGERMYALKYNE COMPOUND PROMOTER AIR PRODUCTS AND CHEMICALS, INC. (US) 1990-02-20 US disclosed
EP-0343556-A2 Process for the polymerization of tri-substituted silylalkynes AIR PRODUCTS AND CHEMICALS, INC. (US) 1989-11-29 EP disclosed
EP-0339516-A2 Catalyst and process for the preparation of polymers of tri-substituted silylalkynes AIR PRODUCTS AND CHEMICALS, INC. (US) 1989-11-02 EP disclosed
US-4835229-A METAL HALIDE, TERTIARY AMINE AIR PRODUCTS AND CHEMICALS, INC. (US) 1989-05-30 US disclosed